PDS Pathology Data Systems

PDS Life Sciences is a global provider of software and services for the life sciences industry, specializing in preclinical research and pathology data management. The company's core product, the Ascentos software suite, facilitates the collection, management, and reporting of toxicology and pathology data for pharmaceutical companies and contract research organizations. PDS is particularly recognized for its expertise in SEND (Standard for Exchange of Nonclinical Data) services, helping clients meet FDA regulatory requirements for electronic data submission. In addition to software, the company provides expert consultancy and outsourced data management services to streamline the drug development process. Following its acquisition by Xybion Digital in 2021, PDS has integrated its specialized tools into a broader ecosystem of laboratory information management systems.